Financials

About
Research
Clinical Trials
Licensed Products
- HCV Licensed Products
News
Careers
Investors

About
Research
Clinical Trials
Licensed Products
- HCV Licensed Products
News
Careers
Investors

Quarterly Results

Fiscal Year:

Quick Links

Investor FAQs
Governance Documents
SEC Filings

IR Contact

Carol Miceli

Director, Investor Relations

Enanta Pharmaceuticals, Inc.

Phone: 617-607-0710

Email: cmiceli@enanta.com

Investor Alerts

To receive notifications via email, enter your email address and select at least one subscription below. After submitting your information, you will receive an email. You must click the link in the email to activate your subscription. You can sign up for additional subscriptions at any time.

* Required

Email Address *

Mailing Lists *

News

Events & Presentations

Quarterly Results

Annual Reports

SEC Filings

End of Day Stock Quote



Enter the code shown above.
*

Email Alert Sign Up Confirmation

About
Research
Licensed Products
News
Careers
Investors

Copyright Enanta Pharmaceuticals, Inc

Privacy Policy
Twitter Policy
Terms Of Use

Powered By Q4 Inc. 5.21.0.3 (opens in new window)